연구성과로 돌아가기

2023 연구성과별 연구자 정보 (1464 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Andre, Thierry Andre, T 1 교신저자 Sorbonne Univ, Hop St Antoine, Dept Med Oncol, F-75012 Paris, France N-8830-2017 André, Thierry 0000-0002-5103-7095 Andre, Thierry thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Pietrantonio, Filippo Pietrantonio, F 2 Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, I-20133 Milan, Italy C-2180-2017 Pietrantonio, Filippo 0000-0002-8530-8420 Pietrantonio, Filippo thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Avallone, Antonio Avallone, A 3 IRCCS Fdn G Pascale, Ist Nazl Tumori, Dept Abdominal Oncol, I-80131 Naples, Italy K-4662-2016 Avallone, Antonio 0000-0001-6188-5664 Avallone, Antonio thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Gumus, Mahmut Gumus, M 4 Istanbul Medeniyet Univ, Goztepe Prof Dr Suleyman Yalcin City Hosp, Dept Med Oncol, TR-34700 Istanbul, Turkiye HTO-4176-2023 Gumus, Mahmut 0000-0003-3550-9993 Gumus, Mahmut thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Wyrwicz, Lucjan Wyrwicz, L 5 Narodowy Inst Onkol Marii Sklodowskiej Curie, Klin Onkol & Radioterapii, PL-00001 Warsaw, Poland thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Kim, Jong Gwang Kim, JG 6 Kyungpook Natl Univ, Sch Med, Dept Obstet & Gynecol, Daegu 41404, South Korea thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Yalcin, Suayib Yalcin, S 7 Hacettepe Univ, Dept Med Oncol, TR-06230 Ankara, Turkiye KWT-7106-2024 Yalcin, Suayib thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Kwiatkowski, Mariusz Kwiatkowski, M 8 Szpital Wojewodzki Mikolaja Kopern Koszalinie, Dept Oddzial Dzienny Chemioterapii, PL-75581 Koszalin, Poland thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Lonardi, Sara Lonardi, S 9 Veneto Inst Oncol IRCCS, Dept Oncol, I-31033 Padua, Italy F-4228-2014 Lonardi, Sara thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Zolnierek, Jakub Zolnierek, J 10 LuxMed Onkol Warszawa, Ul Szamocka 6, PL-01748 Warsaw, Poland thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Odeleye-Ajakaye, Amos Odeleye-Ajakaye, A 11 Merck & Co Inc, Rahway, NJ USA thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Leconte, Pierre Leconte, P 12 MSD France, Dept Med Oncol, F-92800 Puteaux La Defense, France thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Fogelman, David Fogelman, D 13 Merck & Co Inc, Rahway, NJ USA thierry.andre@aphp.fr;
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer Kim, Tae Won Kim, TW 14 Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul 05505, South Korea GRX-7323-2022 Kim, Tae Won thierry.andre@aphp.fr;
Kidney complications associated with COVID-19 infection and vaccination in children and adolescents: a brief review Baek, Hee Sun Baek, HS 1 Yeungnam Univ, Dept Pediat, Coll Med, Daegu, South Korea 0000-0003-0940-360X Baek, Hee Sun chomh@knu.ac.kr;
페이지 이동: